Abstract
Background:Myrsine africana (MA) is a plant traditionally used in South Africa to treat various diseases.Objective:The ethanolic extract of MA, was used for in vitro and in vivo studies to determine its elastase inhibitory activity.Materials and Methods:MA and its isolated compound, myrsinoside B, were tested in vitro for their elastase inhibitory activity. The MA extract was also evaluated for mutagenicity using two strains of Salmonella typhimurium (TA 98 and TA 100), microbial count, metal analysis, and stability. In vivo studies included irritancy and wrinkle reduction trials using Visioscan and Visioface.Results:The leaf extract showed good elastase inhibition with a 50% inhibitory concentration (IC50) of 28.04 μg/ml. Myrsinoside B inhibited the elastase enzyme at an IC50 of 4.68 ± 0.34 μg/ml. No colony growth observed during mutagenicity studies and it was concluded that MA ethanolic extract is a nonmutagen. MA extract was found to be a nonirritant during the patch test clinical trial. MA was found to contain negligible amounts of microorganisms and heavy metals. Gel cream containing MA crude extract was found to be stable for 2 years when kept at temperatures below 30°C. In clinical trials (in vivo), it was found that the test product containing 5% ethanolic extract of MA was effective in reducing wrinkles after application 2 times a day for 14 days and 28 days compared to the placebo aqueous cream.Conclusion:MA is effective in reducing the appearance of wrinkles.SUMMARY This is a first time report of the elastase inhibitory potential of Myrsine africana and myrsinoside B and the anti-wrinkle potential of Myrsine africanaMyrsine africana ethanolic extract effectively inhibited the elastase enzymeMyrsine africana was effective in in vivo studies to reduce the appearance of wrinkles after 14 days. Abbreviations used: 4-NQO: 4-nitroquinoline, D14-BL: Baseline to day fourteen, D28-BL: Baseline to day twenty-eight, CFU: Colony forming units, IC50: 50% inhibitory concentration, MA: Myrsine africana, MOU: Measurement of uncertainty, NaCl: Sodium chloride, NaH2 PO4.H2O: Sodium phosphate monobasic monohydrate, SEM: Standard error of the mean, TA 98: Salmonella typhimurium strain 98, TA 100: S. typhimurium strain 100, TLC: Thin layer chromatography, TMA: Total microbial activity, XVB salt: Vogel-Bonner medium E.
Highlights
Myrsine africana (MA) belonging to the Myrsinaceae family is a small shrub known as the Cape Myrtle, African boxwood or Thakisa
Elastase inhibition assay on ethanolic leaf extract of Myrsine africana and compound The leaf extract for MA was evaluated for its elastase inhibitory activity using the elastase inhibition assay
The isolated compound myrsinoside B was further evaluated for its elastase inhibitory activity and found to have an 50% inhibitory concentration (IC50) of 4.68 ± 0.34 μg/ml [Table 1]
Summary
Myrsine africana (MA) belonging to the Myrsinaceae family is a small shrub known as the Cape Myrtle, African boxwood or Thakisa. The plant is indigenous to Macaronesia, Africa, and South Asia. It is found throughout South Africa, commonly in areas where summer and winter rainfall occurs. Myrsine africana (MA) is a plant traditionally used in South Africa to treat various diseases. Objective: The ethanolic extract of MA, was used for in vitro and in vivo studies to determine its elastase inhibitory activity. Materials and Methods: MA and its isolated compound, myrsinoside B, were tested in vitro for their elastase inhibitory activity. In clinical trials (in vivo), it was found that the test product containing 5% ethanolic extract of MA was effective in reducing wrinkles after application 2 times a day for 14 days and 28 days compared to the placebo aqueous cream.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.